US 2015/0203464 A1 · COMPOUNDS FOR SUPPRESSING A PERIPHERAL NERVE DISORDER INDUCED BY AN ANTI-CANCER AGENT

Abstract

The present invention provides a medicament that suppresses (or mitigates) various neurological symptoms caused by a peripheral nerve disorder induced by an anti-cancer agent.

Claims1

Dependent claims

Ethyl (3S)-3-[N-(2-chloro-4-fluorophenyl)sulfamoyl]-3,6-dihydro-2H-pyran-4-carboxylate or a salt thereof or a prodrug thereof.

Dependencies are inferred from the claim text.

Facts

Application

14/676,947Filed 2 Apr 2015

Priority

JP 2010-01593527 Jan 2010

Published

23 Jul 2015

Term ends

Not estimatedThe source records don’t support an estimate.

Classification26 codes

A61K 31/216
Of carboxylic acids: of acids having aromatic rings, e.g. benactizyne, clofibrate
A61K 31/235
Of carboxylic acids: having an aromatic ring attached to a carboxyl group
A61K 31/282
Compounds containing heavy metals: platinum compounds
A61K 31/337
Having oxygen as the only ring hetero atom, e.g. fungichromin: having four-membered rings, e.g. taxol

Family

Application13/574,848Continuation · filed 15 Oct 2012

Application13/971,159Continuation · filed 20 Aug 2013

Application14/525,576Continuation · filed 28 Oct 2014

Application14/676,947Continuation

US 2013/0046000 A1Published application

US 2013/0345304 A1Published application

US 2015/0051256 A1Published application

US 8,901,171 B2Related patent

US 2015/0203464 A1This patent

From the US filing history. Foreign family members aren’t listed.

Abstract

The present invention provides a medicament that suppresses (or mitigates) various neurological symptoms caused by a peripheral nerve disorder induced by an anti-cancer agent.

Compounds for suppressing a peripheral nerve disorder induced by an anti-cancer agent

Life of this patent

Abstract

Claims1

Compounds for suppressing a peripheral nerve disorder induced by an anti-cancer agent

Life of this patent

Abstract

Claims1